CZS-241

N/A

Report date: 2023/02/07 10:59:14
NME

Base Information

Drug NameCZS-241
Drug Alias NameCZS-241
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 4 inhibitors
TargetsPolo like kinase 4
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A